PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
70.23
ESG score 1.1-1.2x ADAP's 62.74. Guy Spier would verify if superior ESG practices translate to better stakeholder relationships.
70.45
Environmental score exceeding 1.2x ADAP's 50.00. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
73.58
Social score 90-95% of ADAP's 78.41. Bill Ackman would demand clear social improvement catalysts.
66.65
Governance score 1.1-1.2x ADAP's 59.80. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.